Biotech · Private company · Exton, PA, US
Serentrix, LLC
Track this companyFree. Adds Serentrix, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Topical treatment for burn pain by blocking cutaneous pain receptors.Fiscal year 2025 · $6.5KNIH RePORTER 3R43GM150295-01A1S1 · fetched Nov 12, 2026
- Validating SER-014, a TRPV1 antagonist, to treat endometriosisFiscal year 2024 · $384.4KNIH RePORTER 1R41HD115418-01 · fetched Nov 12, 2026
- Topical treatment for burn pain by blocking cutaneous pain receptors.Fiscal year 2024 · $340.7KNIH RePORTER 1R43GM150295-01A1 · fetched Nov 12, 2026